A meta-analysis of the clinical remission rate and long-term efficacy of tonsillectomy in patients with IgA nephropathy

Nephrology Dialysis Transplantation

Volumn 26, Issue 6, 2011, Pages 1923-1931

  Wang, You ^a   Chen, Junying ^a   Wang, Yan'E ^a   Chen, Yan ^a   Wang, Le ^a   Lv, Yongman ^a  

^a TONGREN HOSPITAL OF WUHAN UNIVERSITY   (China)

Author keywords

clinical remission; IgA nephropathy; long term efficacy; steroid; tonsillectomy

Indexed keywords

CYTOTOXIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIPYRIDAMOLE; IMMUNOSUPPRESSIVE AGENT; STEROID;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DRUG PULSE THERAPY; FOLLOW UP; HUMAN; IMMUNOGLOBULIN A NEPHROPATHY; INTERMETHOD COMPARISON; KIDNEY FAILURE; MAJOR CLINICAL STUDY; META ANALYSIS; OUTCOME ASSESSMENT; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; REMISSION; SURVIVAL RATE; SYSTEMATIC REVIEW; TONSILLECTOMY;

CASE-CONTROL STUDIES; GLOMERULONEPHRITIS, IGA; HUMANS; REMISSION INDUCTION; RETROSPECTIVE STUDIES; TONSILLECTOMY; TREATMENT OUTCOME;

EID: 79958114303     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq674     Document Type: Article

References (27)

1. Osamu H, Mariko M et al. Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy. Am J Kidney Dis 2001; 38: 736-743.
2. Sato M, Hottaa O et al. Cohort study of advanced IgA nephropathy: efficacy and limitations of corticosteroids with tonsillectomy. Nephron Clin Pract 2003; 93: c137-c145.
3. Hirofumi A, Michiya K et al. Long-term results of tonsillectomy as a treatment for IgA nephropathy. Acta Otolaryngol 2004; 555: 38-42.
4. Shinichi N, Yuansheng X et al. A clinicopathological study on the long-term efficacy of tonsillectomy in patients with IgA nephropathy. Acta Otolaryngol 2004; 555: 49-53.
5. Mariko M, Osamu H et al. A multicenter prospective cohort study of tonsillectomy and steroid therapy in Japanese patients with IgA nephropathy: a 5-year report. Contrib Nephrol Basel 2007; 157: 94-98.
6. Komatsu H, Fujimoto S et al. Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study. Clin J Am Soc Nephrol 2008; 3: 1301-1307.
7. Chen Y, Tang Z et al. Long-term efficacy of tonsillectomy in Chinese patients with IgA nephropathy. Am J Nephrol 2007; 27: 170-175. (Pubitemid 46588183)
8. De Fijter JW, Eijgenraam JW, Baaam CA et al. Deficient IgA immune response to nasal cholera toxin subunit B in primary IgA nephropathy. Kidney Int 1996; 50: 952-961. (Pubitemid 26302685)
9. Berger J, Hinglais N. Les depots intercapillaires d'IgA-IgG. J Urol Nephrol (Paris) 1968; 74: 694-695.
10. Emancipator SN. IgA nephropathy: morphologic expression and pathogenesis. Am J Kidney Dis 1994; 23: 451-462. (Pubitemid 24081387)
11. D'Amico G, Colasanti G et al. Long-term follow-up of IgA mesangial nephropathy: clinico-histological study in 374 patients. Semin Nephrol 1987; 7: 355-358.
12. Ibrls LS, Gyory AZ. IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 1994; 73: 79-102. (Pubitemid 24114627)
13. Hogg RJ, Silva FG, Wyatt RJ et al. Prognostic indicators in children with IgA nephropathy-report of the Southwest Pediatric Nephrology Study Group. Pediatr Nephrol 1994; 8: 15-20. (Pubitemid 24042359)
14. Radford MGJR, Donadio JV Jr, Bergstralh EJ et al. Predicting renal outcome in IgA nephropathy. J Am Soc Nephrol 1997; 8: 199-207. (Pubitemid 127455874)
15. Nishi S. The prognosis of IgA nephropathy-favorable or poor? Intern Med 2001; 40: 679-680.
16. Maisonneuve P, Agodoa L, Gellert R et al. Distribution of primary renal diseases leading to end-stage renal failure in the United States, Europe, and Australia/New Zealand: results from an international comparative study. Am J Kidney Dis 2000; 35: 157-165. (Pubitemid 30027256)
17. Briganti EM, Dowling J, Finlay M et al. The incidence of biopsyproven glomerulonephritis in Australia. Nephrol Dial Transplant 2001; 16: 1364-1367.
18. Donadio JV, Grande JP. IgA nephropathy. N Engl J Med 2002; 347: 738-748. (Pubitemid 35203906)
19. Bernstein JM. Mucosal immunology of the upper respiratory tract. Respiration 1992; 59: 3-13.
20. Egido J, Blasco R, Lozano L et al. Immunological abnormalities in the tonsils of patients with IgA nephropathy: inversion in the ratio of IgA: IgG bearing lymphocytes and increased polymeric IgA synthesis. Clin Exp Immunol 1984; 57: 101-106. (Pubitemid 14083833)
21. Harper SJ, Allen AC, BeneMC et al. Increased dimeric IgA-producing B cells in tonsils in IgA nephropathy determined by in situ hybridization for J chain mRNA. Clin Exp Immunol 1995; 101: 442-448.
22. Rifai A, Small PA Jr, Teague PO et al. Experimental IgA nephropathy. J Exp Med 1979; 150: 1161-1173. (Pubitemid 10249941)
23. Harper SJ, Feehally J. The pathogenic role of immunoglobulin A polymers in immunoglobulin A nephropathy. Nephron 1993; 65: 337-345. (Pubitemid 23321227)
24. Tomino Y, Sakai H, Endoh M et al. Cross-reactivity of IgA antibodies between renal mesangial areas and nuclei of tonsillar cells in patients with IgA nephropathy. Clin Exp Immunol 1983; 51: 605-610. (Pubitemid 13144139)
25. Suzuki S, Nakayomi Y, Sato H et al. Haemophilus parainfluenzae antigen and antibody in renal biopsy samples and serum of patients with IgA nephropathy. Lancet 1994; 343: 12-16.
26. Suzuki S, Fujieda S, Sunaga H et al. Immune response of tonsillar lymphocytes to Haemophilus parainfluenzae in patients with IgA nephropathy. Clin Exp Immunol 2000; 119: 328-332. (Pubitemid 30073038)
27. Yamamoto C, Suzuki S, Kimura H et al. Experimental nephropathy induced by Haemophilus parainfluenzae antigens. Nephron 2002; 90: 320-327 (Pubitemid 34195759)